Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:609019.
doi: 10.1155/2013/609019. Epub 2013 Dec 18.

Mild systemic oxidative stress in the subclinical stage of Alzheimer's disease

Affiliations

Mild systemic oxidative stress in the subclinical stage of Alzheimer's disease

Leandro Giavarotti et al. Oxid Med Cell Longev. 2013.

Abstract

Alzheimer's disease (AD) is a late-onset, progressive degenerative disorder that affects mainly the judgment, emotional stability, and memory domains. AD is the outcome of a complex interaction among several factors which are not fully understood yet; nevertheless, it is clear that oxidative stress and inflammatory pathways are among these factors. 65 elderly subjects (42 cognitively intact and 23 with probable Alzheimer's disease) were selected for this study. We evaluated erythrocyte activities of superoxide dismutase, catalase, and glutathione peroxidase as well as plasma levels of total glutathione, α-tocopherol, β-carotene, lycopene, and coenzyme Q10. These antioxidant parameters were confronted with plasmatic levels of protein and lipid oxidation products. Additionally, we measured basal expression of monocyte HLA-DR and CD-11b, as well as monocyte production of cytokines IL1-α, IL-6, and TNF-α. AD patients presented lower plasmatic levels of α-tocopherol when compared to control ones and also higher basal monocyte HLA-DR expression associated with higher IL-1α production when stimulated by LPS. These findings support the inflammatory theory of AD and point out that this disease is associated with a higher basal activation of circulating monocytes that may be a result of α-tocopherol stock depletion.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative flow cytometric analysis of whole blood samples stained with anti-CD11b-APC (right column) and anti-HLA-DR-PE (left column) monoclonal antibodies. From all events acquired in gate R1 (upper left graph), CD14-positive monocytes (gate R2, separated from CD66b-positive neutrophils in gate R3; upper right graph) were used for histogram calculation of the geometric mean fluorescence intensity (GMFI). A similar analysis was performed for the detection of fluorescent DCF in the ROS assay (histogram not shown). INT (sample from cognitively intact patient) and AD (sample from patient with probable Alzheimer's disease).
Figure 2
Figure 2
Representative flow cytometric detection of monocyte intracellular production of IL-1α, IL-6, and TNF-α. Monocytes were selected in a similar manner as described in Figure 1. LPS-induced production of each cytokine was determined by the percentage of events in the upper right quadrant (%URQ). Only upper quadrants are shown. INT (sample from cognitively intact patient) and AD (sample from patient with probable Alzheimer's disease).

Similar articles

Cited by

References

    1. Dickerson BC, Bakkour A, Salat DH, et al. The cortical signature of Alzheimer’s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cerebral Cortex. 2009;19(3):497–510. - PMC - PubMed
    1. Jana A, Pahan K. Fibrillar amyloid-β peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase: Implications for Alzheimer’s disease. Journal of Biological Chemistry. 2004;279(49):51451–51459. - PMC - PubMed
    1. Finch CE, Morgan TE. Inflammatory processes of Alzheimer disease and aging. Proceedings of the Indian National Science Academy B. 2003;69:165–178.
    1. Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D. Inflammation in Alzheimer’s disease: relevance to pathogenesis and therapy. Alzheimer’s Research and Therapy. 2010;2(1, article 1) - PMC - PubMed
    1. Rojo LE, Fernández JA, Maccioni AA, Jimenez JM, Maccioni RB. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer’s disease. Archives of Medical Research. 2008;39(1):1–16. - PubMed

LinkOut - more resources